Daejeon
South Korea
22
2025-12-04
16
2026-05-05
These are the the leading inventors for applications assigned to ALTEOGEN, INC:
ALTEOGEN, INC based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NOVEL HYALURONIDASE VARIANTS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#2 | 2025-05-01METHOD FOR PRODUCING RECOMBINANT HYALURONIDASE
#3 | 2025-04-24METHOD FOR PRODUCING RECOMBINANT HYALURONIDASE
#4 | 2025-01-09PHARMACEUTICAL COMPOSITION COMPRISING HUMAN HYALURONIDASE PH20 AND DRUG
#5 | 2023-08-10 ✅ Patent 12,618,055 granted on 2026-05-05NOVEL HYALURONIDASE VARIANTS WITH IMPROVED STABILITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#6 | 2023-06-08 ✅ Patent 12,221,638 granted on 2025-02-11Method for producing recombinant hyaluronidase
#7 | 2022-11-03METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN
#8 | 2022-04-07 ✅ Patent 12,090,210 granted on 2024-09-17Antibody-drug conjugate comprising modified antibody
#9 | 2021-11-25 ✅ Patent 12,570,766 granted on 2026-03-10PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION COMPRISING HUMAN HYALURONIDASE PH20 VARIANT AND DRUG
#10 | 2021-05-27 ✅ Patent 12,371,683 granted on 2025-07-29NOVEL HYALURONIDASE VARIANTS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#11 | 2021-01-14 ✅ Patent 11,866,492 granted on 2024-01-09Antibody specifically binding to FOLR1 and uses thereof
#12 | 2020-12-24 ✅ Patent 11,981,719 granted on 2024-05-14Growth hormone receptor antagonists and fusion proteins thereof
#13 | 2020-08-13 ✅ Patent 11,235,065 granted on 2022-02-01Antibody-drug conjugate comprising modified antibody
#14 | 2018-10-18 ✅ Patent 11,414,476 granted on 2022-08-16Method for producing fusion protein having IgG Fc domain
#15 | 2017-05-04MODIFIED ANTIBODY IN WHICH MOTIF COMPRISING CYSTEINE RESIDUE IS BOUND, MODIFIED ANTIBODY-DRUG CONJUGATE COMPRISING THE MODIFIED ANTIBODY, AND PRODUCTION METHOD FOR SAME
#16 | 2016-12-29 ✅ Patent 9,982,032 granted on 2018-05-29Stable liquid formulation of fusion protein with IgG Fc domain
#17 | 2016-04-28 ✅ Patent 9,821,059 granted on 2017-11-21Composition for stabilizing protein and pharmaceutical formulation comprising the same
#18 | 2016-04-14 ✅ Patent 9,814,782 granted on 2017-11-14Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
#19 | 2015-11-05 ✅ Patent 9,474,803 granted on 2016-10-25Composition for stabilizing fusion protein in which protein and FC domain are fused
#20 | 2015-05-07 ✅ Patent 9,902,753 granted on 2018-02-27Method of purifying a long-acting human growth hormone
#21 | 2014-12-18 ✅ Patent 9,051,395 granted on 2015-06-09Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#22 | 2012-04-19 ✅ Patent 9,012,606 granted on 2015-04-21In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same
Also check out ALTEOGEN, INC.'s (Daejeon, South Korea) applicant profile with 19 patent applications submitted.
84928 ⎘